Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3054101000168118 | Visipaque (iodixanol 550 mg / 1 mL) injection, 10 x 50 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3054111000168115 | Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | Is a | iodixanol 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | has TPUU | Visipaque 550 mg (iodine 270 mg)/mL injection, 50 mL vial | true | Inferred relationship | Some | 1 | |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | has TP | Visipaque | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | Is a | True | Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 50 mL vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR